We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Fine-Tuning the Bioproduction of Drugs

News   Apr 22, 2021 | Original story from Northwestern University

 
Fine-Tuning the Bioproduction of Drugs

Taxol, the anti-cancer drug, is produced naturally in the bark of Pacific Yew trees, which take 80 years to grow. Credit: National Cancer Institute

 
 
Advertisement
 

RELATED ARTICLES

Initial Immune Response Key to Preventing Pandemics

News

New research suggests that a host's initial immune response has a central role in determining whether infection occurs and the degree to which it spreads within a population.

READ MORE

New Technology Transports the Genes for Therapeutic Agents Directly Into Tumor Cells

News

A new technology from UZH researchers enables the body to produce therapeutic agents on demand at exactly the point where they are needed. The innovation could reduce the side effects of cancer therapy and help better deliver COVID-19 treatments to the lungs.

READ MORE

Improving the Quality and Safety of Heparin

News

A team has analyzed Heparin, the blood-thinning drug, using a new method to that can pinpoint contaminants more accurately and quickly, providing greater quality control and safety.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE